Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.34
Delayed Data
As of May 28
 -0.02 / -0.21%
Today’s Change
2.65
Today|||52-Week Range
16.87
-23.76%
Year-to-Date

Today’s Trading

Previous close9.36
Today’s open9.36
Day’s range-- - --
Volume2,546,324
Average volume (3 months)3,547,781
Market cap$1.1B
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+7.31%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.76

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.08+1.19%
ARRYArray Biopharma Inc-0.10-1.29%
SRPTSarepta Therapeutics...-0.63-2.41%
TXMDTherapeuticsMD Inc+0.11+1.66%
Data as of 05/28/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers